Carnegie Lake Advisors’s RxSight RXST Stock Holding History

Carnegie Lake Advisors’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$953K	Sell	154,745 -7,100	-4%	-$59K	0.38%	71
2025 Q4	$1.69M	Sell	161,845 -32,500	-17%	-$326K	0.64%	36
2025 Q3	$1.75M	Buy	194,345 +87,345	+82%	+$767K	0.67%	36
2025 Q2	$1.39M	Buy	+107,000	New	+$1.61M	0.55%	50

Other funds holding RXST

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

NSGL

No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Carnegie Lake Advisors's RXST Position: Q1 2026 in Review

Carnegie Lake Advisors reduced its RxSight (RXST) stake by 4.4% in Q1 2026, selling an estimated $59K and leaving 154,745 shares worth $953K. The position accounts for 0.38% of the portfolio, ranked #71.

Carnegie Lake Advisors first reported a position in RXST in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.75M in Q3 2025. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

Carnegie Lake Advisors held 154,745 shares of RxSight worth $953K as of Q1 2026.
Carnegie Lake Advisors sold 7,100 RxSight shares in Q1 2026, an estimated $59K.
RxSight made up 0.38% of Carnegie Lake Advisors's portfolio in Q1 2026, its #71 holding.
Carnegie Lake Advisors first reported a position in RxSight in Q2 2025 and has held it in 4 quarters since.
Carnegie Lake Advisors's RxSight position peaked at $1.75M in Q3 2025.
164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on Carnegie Lake Advisors's 13F filing for Q1 2026, filed 29 Apr 2026.